Citation:Bohelay G, Battistella M, Pagès C, de Margerie-Mellon C, Basset-Seguin N, Viguier M, et al 2015
From Cancer Guidelines Wiki
Citation
Bohelay G, Battistella M, Pagès C, de Margerie-Mellon C, Basset-Seguin N, Viguier M, et al. Ultrasound-guided core needle biopsy of superficial lymph nodes: an alternative to fine-needle aspiration cytology for the diagnosis of lymph node metastasis in cutaneous melanoma. Melanoma Res 2015 Apr 29 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25933210.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?, Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?, Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?, Clinical question:How should patients at each stage of melanoma be followed after initial definitive treatment?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span>, <span class="smw-value">Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?</span>, <span class="smw-value">Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?</span>, <span class="smw-value">Clinical question:How should patients at each stage of melanoma be followed after initial definitive treatment?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?, Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?, Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?, Clinical question:How should patients at each stage of melanoma be followed after initial definitive treatment?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic Stage I and II patients?</span>, <span class="smw-value">Clinical question:What investigations should be performed when in transit and/or regional node disease (Stage III melanoma) is diagnosed?</span>, <span class="smw-value">Clinical question:What investigations should be performed when Stage IV melanoma is diagnosed?</span>, <span class="smw-value">Clinical question:How should patients at each stage of melanoma be followed after initial definitive treatment?</span></span></span></span>»]] (compare critical appraisals)
Cited by
- Follow up after initial definitive treatment for each stage of melanoma
- What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients?
- What investigations should be performed when in-transit and/or regional node disease (stage III melanoma) is diagnosed?